{
    "2018-06-14": [
        [
            {
                "time": "",
                "original_text": "【医药丨周小刚】凯莱英(002821)：创新药 CDMO 需求持续提升， 技术驱动长期可持续发展",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "创新药",
                        "CDMO",
                        "需求持续提升",
                        "技术驱动",
                        "长期可持续发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}